참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Ethyl Acetate | HCID 8857 | — |
| 반응물 | Ethyl orthoformate | HCID 31214 | — |
| 반응물 | p-Toluenesulfonic acid monohydrate | HCID 521998 | — |
| 반응물 | 5-(Benzoxazol-2-yl)-2-(tetrahydropyran-4-yl)aminoaniline | HCID 67498806 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | 5-(Benzoxazol-2-yl)-1-(tetrahydropyran-4-yl)benzimidazole | HCID 67497722 | 31.5% |
반응 단계
To 5-(benzoxazol-2-yl)-2-(tetrahydropyran-4-yl)aminoaniline (see Working Example 20-2) (0.20 g, 0.646 mmol), triethyl orthoformate (5 mL) was added a catalytic amount of p-toluenesulfonic acid monohydrate, and this was heated to 100° C. for 1.5 hours. The reaction mixture was cooled, ethyl acetate and water added, and this was extracted. This was washed with water, dried over magnesium sulfate, and after concentration the precipitated crystals were filtered off. These were washed with a hexane/ethyl acetate mixture solution, and dried to yield the title compound (65 mg, 31.5% yield) as light reddish-brown crystals.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08829035B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_09 |
|---|
| ORD ID | ord-7fb7c65b3cb14bfebba4c88cb89f09ce |
|---|
| 출처 메모 | uspto-grants-2014_09 |
|---|